A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (XPF-010-303)

Project: Clinical studies › Clinical Study (Industry project)

Status	Active
Effective start/end date	15.12.2024 → 31.12.2030

Project Details